Panoptive
New accelerator entry · 2025-07-24 · the record
We turn unstructured monitoring data - monitoring visit reports, EDC data - into structured deviation, safety, and quality findings for human review. Panoptive generates an audit-ready oversight trail as a natural byproduct.
Panoptive is a Y Combinator company in the Summer 2025 batch. Its directory entry describes it as: The continuous oversight engine for clinical trials. The founder listed is Youssef Kallel (Founder/CEO) (Y Combinator directory entry, July 24, 2025).
Sell to companies like Panoptive? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New accelerator entry · 2025-07-24 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Panoptive.
Free to see. No signup.
More on Panoptive and the records around it.
Get an email when Panoptive changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Panoptive raises, hires or launches. No email unless you switch it on.
Watch Panoptive →Get the full cited report on Panoptive
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Panoptive: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
We turn unstructured monitoring data - monitoring visit reports, EDC data - into structured deviation, safety, and quality findings for human review. Panoptive generates an audit-ready oversight trail as a natural byproduct. The platform aggregates findings and identifies systemic patterns across sites and subjects before they compound, and tracks every finding through decision, follow-up, and resolution.
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Panoptive: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Panoptive covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist PanoptiveYou get an alert in MentionFox the next time this company shows up.
If you're behind Panoptive: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.
Each opens in a new tab, filled in for Panoptive. With no account yet, you sign up free and land on the result.
Cloud infrastructure startups Healthcare and health tech startups
Share the news. Sharing needs no account.

https://mentionfox.com/funding/yc-panoptive